The basic principle in the Biocidal Products Regulation ((EU) No 528/2012 (BPR)) is that a biocidal product (BP) must be authorised before it can be made available on the market or used in the European Union (EU)/ European Economic Area (EEA).
This takes place in two consecutive steps. As the first step, the active substance is evaluated and, provided the criteria are fulfilled, is then approved in a specified product-type (PT). The second step is the authorisation of each BP consisting of, containing or generating the approved active substance(s).
This document concerns the first step, approval of active substances.
October 2016
Collegati
ID 29562 | 11.10.2023
V. 4.0 Febbraio 2023 - IT/EN
European product categorisati...
Modifiche ed integrazioni alla legge 31 dicembre 1962, n. 1860, sull'impiego pacifico dell'energia nucleare.
(GU n.112 del 09.05.1966)
Collegati
Legge 31 dicembre...
ID 19497 | 25.04.2023
Guidance on sampling, analysis and data reporting for the monitoring of miner...
Testata editoriale iscritta al n. 22/2024 del registro periodici della cancelleria del Tribunale di Perugia in data 19.11.2024
